Growth Metrics

Vycor Medical (VYCO) Gross Profit (2016 - 2025)

Vycor Medical has reported Gross Profit over the past 16 years, most recently at $335370.0 for Q4 2025.

  • Quarterly Gross Profit fell 15.61% to $335370.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 9.74% year-over-year, with the annual reading at $1.6 million for FY2025, 9.74% up from the prior year.
  • Gross Profit was $335370.0 for Q4 2025 at Vycor Medical, down from $451932.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $452099.0 in Q2 2021 and troughed at $234113.0 in Q4 2022.
  • The 5-year median for Gross Profit is $315116.5 (2022), against an average of $331994.0.
  • Year-over-year, Gross Profit soared 102.03% in 2021 and then crashed 33.63% in 2022.
  • A 5-year view of Gross Profit shows it stood at $241946.0 in 2021, then fell by 3.24% to $234113.0 in 2022, then increased by 13.72% to $266229.0 in 2023, then skyrocketed by 49.26% to $397382.0 in 2024, then decreased by 15.61% to $335370.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Gross Profit are $335370.0 (Q4 2025), $451932.0 (Q3 2025), and $415271.0 (Q2 2025).